Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
The patient has never received Twinrix second dose.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 45-year-old female patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (Patient received first dose of Twinrix 10 years ago). On an unknown date, the patient did not receive the 2nd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced incomplete course of vaccination (Verbatim: The patient has never received Twinrix second dose.). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 20-MAR-2025 The pharmacist reported that a 45 year-old female patient received Twinrix first dose 10 years ago in another facility and she has never received Twinrix second dose. Till the time of reporting, the patient did not received the second dose of Twinrix which led to incomplete course of vaccination. The Vaccine Administration Facility is the same as primary reporter.